Research Analysts’ Weekly Ratings Changes for Intuitive Surgical (ISRG)

Intuitive Surgical (NASDAQ: ISRG) recently received a number of ratings updates from brokerages and research firms:

• 10/15/2025 – Intuitive Surgical had its price target lowered by analysts at Robert W. Baird from $600.00 to $536.00. They now have an “outperform” rating on the stock.
• 10/15/2025 – Intuitive Surgical had its price target lowered by analysts at Truist Financial Corporation from $600.00 to $525.00. They now have a “buy” rating on the stock.
• 10/14/2025 – Intuitive Surgical had its price target lowered by analysts at Mizuho from $570.00 to $520.00. They now have a “neutral” rating on the stock.
• 10/13/2025 – Intuitive Surgical was given a new $529.00 price target on by analysts at UBS Group AG.
• 10/13/2025 – Intuitive Surgical had its price target lowered by analysts at BTIG Research from $571.00 to $529.00. They now have a “buy” rating on the stock.
• 10/8/2025 – Intuitive Surgical had its “hold (c+)” rating reaffirmed by analysts at Weiss Ratings.
• 10/7/2025 – Intuitive Surgical had its price target lowered by analysts at Evercore ISI from $535.00 to $450.00. They now have an “in-line” rating on the stock.
• 10/4/2025 – Intuitive Surgical was upgraded by analysts at Wall Street Zen from a “hold” rating to a “buy” rating.
• 10/1/2025 – Intuitive Surgical had its price target lowered by analysts at The Goldman Sachs Group, Inc. from $621.00 to $567.00. They now have a “buy” rating on the stock.
• 10/1/2025 – Intuitive Surgical had its “buy” rating reaffirmed by analysts at BTIG Research. They now have a $571.00 price target on the stock.
• 9/27/2025 – Intuitive Surgical had its “hold (c+)” rating reaffirmed by analysts at Weiss Ratings.
• 9/26/2025 – Intuitive Surgical was downgraded by analysts at Wall Street Zen from a “buy” rating to a “hold” rating.
• 8/22/2025 – Intuitive Surgical had its “sell” rating reaffirmed by analysts at Deutsche Bank Aktiengesellschaft.
• 8/20/2025 – Intuitive Surgical was downgraded by analysts at Zacks Research from a “strong-buy” rating to a “hold” rating.
• 8/19/2025 – Intuitive Surgical had its “outperform” rating reaffirmed by analysts at Royal Bank Of Canada. They now have a $615.00 price target on the stock.

Insider Buying and Selling

In other news, EVP Myriam Curet sold 4,500 shares of the business’s stock in a transaction that occurred on Friday, July 25th. The stock was sold at an average price of $492.48, for a total transaction of $2,216,160.00. Following the completion of the sale, the executive vice president owned 353 shares in the company, valued at $173,845.44. The trade was a 92.73% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available at this hyperlink. Also, insider Gary S. Guthart sold 29,360 shares of the company’s stock in a transaction that occurred on Friday, August 29th. The shares were sold at an average price of $472.49, for a total value of $13,872,306.40. Following the completion of the transaction, the insider directly owned 19,827 shares in the company, valued at $9,368,059.23. The trade was a 59.69% decrease in their position. The disclosure for this sale can be found here. In the last 90 days, insiders sold 45,224 shares of company stock valued at $21,716,492. Company insiders own 0.70% of the company’s stock.

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.